NEU 0.35% $20.17 neuren pharmaceuticals limited

2H, page-8

  1. 669 Posts.
    lightbulb Created with Sketch. 60
    not too sure where you got that. The chairman has told us repeatedly that they were talking to life science funds and other US investors. In addition, he pointed out Lanstead was also placing pressure on the SP. This view is also echoed by his representative (you know the name) who repeatedly stated that he checked the broker data although no evidence was ever produced to back it up
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.